Angion Biomedica Corp.

ACTIVE

纽约州拿骚县, New York, United Stateswww.angion.comPublic101–250 employeesEstablished: 1998-01-01

Part of Elicio Therapeutics

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

1998

Overview

Trial Phase Distribution

Phase

Trials

Phase 2

47.1%

Phase 1

41.2%

Phase 3

5.9%

Trial Status Distribution

Active, not recruiting

17.6%

Completed

11.8%

Terminated

5.9%

Unknown

58.8%

Withdrawn

5.9%

Clinical Trials

Trials sponsored by this organization (17)

Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis

Phase 1

Unknown

interventional

Jun 202220 participants

A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-controlled Study of Safety and Efficacy Of ANG-3070 in Patients with primary proteinuric renal disease

Phase 1

Active, not recruiting

Feb 2022100 participants

Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia

Phase 2

Unknown

interventional

Jul 2020100 participants

ANG-3070 in Healthy Adult Participants

Phase 1

Completed

interventional

Dec 201997 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations

Angion Biomedica Corp.

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (17)

Study to Assess the Safety and Tolerability of ANG-3070 in Subjects With Idiopathic Pulmonary Fibrosis

A Phase 2, Multicenter, Double-Blind, Randomized, Placebo-controlled Study of Safety and Efficacy Of ANG-3070 in Patients with primary proteinuric renal disease

Study of Safety and Efficacy of ANG-3070 in Chronic Kidney Disease

Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects

Study Developed to Evaluate the Effect of ANG-3777 on QT/QTc Interval

A Study to Assess the Absorption, Metabolism and Excretion of [14C]-ANG-3777

Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia

ANG-3070 in Healthy Adult Participants

Approvals

News